MyAverix Finance
F · Healthcare
CytoMed Therapeutics Limited (F98)
Biotechnology
CytoMed Therapeutics Limited (F98) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $10.02M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for F98
CytoMed Therapeutics Limited (F98) — FAQ
What is CytoMed Therapeutics Limited's market cap?
CytoMed Therapeutics Limited (F98) has a reported market cap of $10.02M (data as of 2026-03-29).
What is F98's P/E ratio?
The price-to-earnings (P/E) ratio for CytoMed Therapeutics Limited (F98) is 18.00 (data as of 2026-03-29).
Does CytoMed Therapeutics Limited pay a dividend?
Dividend yield is not available in the current snapshot for CytoMed Therapeutics Limited (F98). Check the MyAverix Finance app for the latest dividend data.
What sector is CytoMed Therapeutics Limited in?
CytoMed Therapeutics Limited (F98) is classified in the Healthcare sector (Biotechnology industry).
What exchange is F98 listed on?
F98 is listed on F.
What is CytoMed Therapeutics Limited's net margin?
CytoMed Therapeutics Limited (F98) reports a net margin of 0.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.